{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:53:36Z","timestamp":1740138816863,"version":"3.37.3"},"reference-count":27,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"Ligue Nationale contre le Cancer, comit\u00e9s de la Dordogne, de la Charente et de la Charente Maritime"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute NCI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.2217\/14622416.7.6.843","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T10:05:38Z","timestamp":1158660338000},"page":"843-852","source":"Crossref","is-referenced-by-count":32,"title":["Relationships Between Genetic Polymorphisms and Anticancer Drug Cytotoxicity\n            <i>Vis-\u00e0-Vis<\/i>\n            the NCI-60 Panel"],"prefix":"10.1080","volume":"7","author":[{"given":"Val\u00e9rie","family":"Le Morvan","sequence":"first","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Bellott","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Moisan","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Mathoulin-P\u00e9lissier","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Robert","sequence":"additional","affiliation":[{"name":"Laboratoire de Pharmacologie des Agents Anticanc\u00e9reux, Institut Bergoni\u00e9, 229 Cours de l\u2018Argonne, 33076Bordeaux-cedex, France. Tel: ; Fax:"},{"name":"Universit\u00e9 Victor Segalen Bordeaux 2, 146 rue L\u00e9o-Saignat33076BORDEAUX-cedex, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2006,9,19]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1038\/35101056"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.01.005"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401723"},{"key":"e_1_3_2_3_4_1","first-page":"4363","volume":"9","author":"van Kuilenburg AB","year":"2003","unstructured":"van Kuilenburg AB , MeinsmaR, ZonnenbergBA et\u00a0al.: Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity. Clin. Cancer Res.9 , 4363\u20134367 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500012"},{"key":"e_1_3_2_3_6_1","first-page":"8654","article-title":"A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.","volume":"61","author":"Park DJ","year":"2001","unstructured":"Park DJ , StoehlmacherJ, ZhangW, Tsao-WeiDD, GroshenS, LenzHJ: A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.Cancer Res.61 , 8654\u20138658 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.12.936"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.11.757"},{"key":"e_1_3_2_3_9_1","first-page":"4285","volume":"57","author":"O\u2018Connor PM","year":"1997","unstructured":"O\u2018Connor PM , JackmanJ, BaeI et\u00a0al.: Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res.57 , 4285\u20134300 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200206000-00010"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(04)00111-8"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/73439"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2258"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/91008"},{"key":"e_1_3_2_3_15_1","first-page":"3577","volume":"56","author":"Ban N","year":"1996","unstructured":"Ban N , TakahashiY, TakayamaT et\u00a0al.: Transfection of glutathione S-transferase (GST)-\u03c0 antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res.56 , 3577\u20133582 (1996).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(01)00447-0"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10870"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.4.641"},{"key":"e_1_3_2_3_19_1","first-page":"1354","volume":"61","author":"Spitz MR","year":"2001","unstructured":"Spitz MR , WuX, WangY et\u00a0al.: Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res.61 , 1354\u20131357 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg120"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.2.275"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1999.1217"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03664"},{"key":"e_1_3_2_3_24_1","first-page":"8634","volume":"63","author":"Roschke AV","year":"2003","unstructured":"Roschke AV , TononG, GehlhausKS et\u00a0al.: Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res.63 , 8634\u20138647 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1612"},{"key":"e_1_3_2_4_2_1","unstructured":"Development Therapeutics Program NCI\/NIH. http:\/\/dtp.nci.nih.gov"},{"key":"e_1_3_2_4_3_1","unstructured":"SKY\/M-FISH and CGH Database. www.ncbi.nlm.nih.gov\/sky\/skyweb.cgi?form_type=submitters"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/14622416.7.6.843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:25:23Z","timestamp":1715981123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/14622416.7.6.843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.2217\/14622416.7.6.843"],"URL":"https:\/\/doi.org\/10.2217\/14622416.7.6.843","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"type":"print","value":"1462-2416"},{"type":"electronic","value":"1744-8042"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}